366 related articles for article (PubMed ID: 25210194)
21. Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines.
Agoni L; Guha C; Lenz J
Front Oncol; 2013; 3():180. PubMed ID: 23847768
[TBL] [Abstract][Full Text] [Related]
22. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
[TBL] [Abstract][Full Text] [Related]
23. Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain.
Hanke K; Kramer P; Seeher S; Beimforde N; Kurth R; Bannert N
J Virol; 2009 Dec; 83(24):12790-800. PubMed ID: 19812154
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.
Tönjes RR; Czauderna F; Kurth R
J Virol; 1999 Nov; 73(11):9187-95. PubMed ID: 10516026
[TBL] [Abstract][Full Text] [Related]
25. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of retroviral restriction factors involved in resistance to porcine endogenous retrovirus.
Bae EH; Jung YT
J Microbiol Biotechnol; 2014 Apr; 24(4):577-83. PubMed ID: 24448163
[TBL] [Abstract][Full Text] [Related]
27. Genome-Wide Screening of Retroviral Envelope Genes in the Nine-Banded Armadillo (Dasypus novemcinctus, Xenarthra) Reveals an Unfixed Chimeric Endogenous Betaretrovirus Using the ASCT2 Receptor.
Malicorne S; Vernochet C; Cornelis G; Mulot B; Delsuc F; Heidmann O; Heidmann T; Dupressoir A
J Virol; 2016 Sep; 90(18):8132-49. PubMed ID: 27384664
[TBL] [Abstract][Full Text] [Related]
28. Reconstitution of an infectious human endogenous retrovirus.
Lee YN; Bieniasz PD
PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
[TBL] [Abstract][Full Text] [Related]
29. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
[TBL] [Abstract][Full Text] [Related]
30. Human endogenous retroviruses and cancer prevention: evidence and prospects.
Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
[TBL] [Abstract][Full Text] [Related]
31. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
32. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
33. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
Vande Burgt NH; Kaletsky RL; Bates P
Viruses; 2015 Oct; 7(10):5587-602. PubMed ID: 26516900
[TBL] [Abstract][Full Text] [Related]
34. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.
Heusinger E; Deppe K; Sette P; Krapp C; Kmiec D; Kluge SF; Marx PA; Apetrei C; Kirchhoff F; Sauter D
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976668
[TBL] [Abstract][Full Text] [Related]
35. Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study.
Mameli G; Erre GL; Caggiu E; Mura S; Cossu D; Bo M; Cadoni ML; Piras A; Mundula N; Colombo E; Buscetta G; Passiu G; Sechi LA
Clin Exp Immunol; 2017 Jul; 189(1):127-131. PubMed ID: 28324619
[TBL] [Abstract][Full Text] [Related]
36. Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase.
Gnirß K; Zmora P; Blazejewska P; Winkler M; Lins A; Nehlmeier I; Gärtner S; Moldenhauer AS; Hofmann-Winkler H; Wolff T; Schindler M; Pöhlmann S
J Virol; 2015 Sep; 89(18):9178-88. PubMed ID: 26109730
[TBL] [Abstract][Full Text] [Related]
37. Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.
Dufrasne FE; Lombard C; Goubau P; Ruelle J
Viruses; 2016 Oct; 8(10):. PubMed ID: 27754450
[TBL] [Abstract][Full Text] [Related]
38. HERV-K: the biologically most active human endogenous retrovirus family.
Tönjes RR; Löwer R; Boller K; Denner J; Hasenmaier B; Kirsch H; König H; Korbmacher C; Limbach C; Lugert R; Phelps RC; Scherer J; Thelen K; Löwer J; Kurth R
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S261-7. PubMed ID: 8797733
[TBL] [Abstract][Full Text] [Related]
39. An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3.
Roebke C; Wahl S; Laufer G; Stadelmann C; Sauter M; Mueller-Lantzsch N; Mayer J; Ruprecht K
Retrovirology; 2010 Aug; 7():69. PubMed ID: 20735848
[TBL] [Abstract][Full Text] [Related]
40. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
Armitage AE; Katzourakis A; de Oliveira T; Welch JJ; Belshaw R; Bishop KN; Kramer B; McMichael AJ; Rambaut A; Iversen AK
J Virol; 2008 Sep; 82(17):8743-61. PubMed ID: 18562517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
